The cancer-associated SF3B1K700E spliceosome mutation confers enhanced sensitivity to BV-6-induced cytotoxicity
The goal was to assess the impact of the SF3B1-K700E mutation on cellular response to various apoptosis-inducing agents using an isogenic CRISPR/Cas9-generated K-562 cell model.